Does Diazoxide Choline Interact with Mao Inhibitors?
CDI records a moderate classification for Diazoxide Choline and Mao Inhibitors. The stored summary is: Concomitant use increases diazoxide exposure, which may increase frequency and/or severity of adverse reactions. Dosage reduction of VYKAT XR recommended. The mechanism involves vykat xr is a cyp1a2 substrate; strong cyp1a2 inhibitors decrease diazoxide metabolism. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This record was extracted from drug labeling through openFDA. NIH/NLM RxNorm is used for drug identities. The summary and severity classification are CDI's processed information, not a verbatim source quotation. Product, route, and patient circumstances matter.
- Severity
- Moderate
- Management
- Monitor for effects
- Data Source
- U.S. FDA via OpenFDA
Recorded Mechanism
VYKAT XR is a CYP1A2 substrate; strong CYP1A2 inhibitors decrease diazoxide metabolism
What To Tell Your Doctor or Pharmacist
If you are taking Diazoxide Choline and your doctor is considering prescribing Mao Inhibitors (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider